THE FOLLOWING INFORMATION WAS OBTAINED FROM THE PHYSICIAN REGISTER SECTION OF THE WEBSITE OF THE COLLEGE OF PHYSICIANS AND SURGEONS OF ONTARIO (WWW.CPSO.ON.CA) AS OF THE DATE AND TIME NOTED BELOW
02/01/25 22:59:11 PM

General Information

Former Name: No Former Name
Medical School: University of Ottawa, 1971
Gender: Man
Languages Spoken: ENGLISH, POLISH

Practice Information

Primary Business Location: Address not Available
Business Email: No Information Available
Phone: No Information Available
Fax: No Information Available

Specialties

No Specialty Reported

Medical Licences In Other Jurisdictions

Effective September 1, 2015, the College by-laws require the College to indicate on the register if the member has a licence or is registered to practise medicine in a jurisdiction outside Ontario, if this is known to the College.
USA - Texas

Hospital Privileges

No information available

General Information

Former Name: No Former Name
Gender: Man
Languages Spoken: ENGLISH, POLISH
Medical School: University of Ottawa, 1971

Practice Information

Primary Business Location: Address not Available
Business Email: No Information Available
Phone: No Information Available
Fax: No Information Available

Specialties

No Specialty Reported

Medical Licences In Other Jurisdictions

Effective September 1, 2015, the College by-laws require the College to indicate on the register if the member has a licence or is registered to practise medicine in a jurisdiction outside Ontario, if this is known to the College.
USA - Texas

Hospital Privileges

No information available

Practice Conditions

This physician is inactive (Expired, Resigned, Suspended, Revoked, or Deceased) and is not permitted to practise medicine.
This physician is inactive (Expired, Resigned, Suspended, Revoked, or Deceased) and is not permitted to practise medicine.

Current Tribunal Proceedings

No information available

Past Tribunal Proceedings

No information available

Other Notifications (2)

Source: Member
Effective Date: 08 Aug 2018
Summary:
Summary of the Undertaking given by Dr. Richard Joseph Kondejewski to the College of Physicians and Surgeons of Ontario, effective August 8, 2018:

A College investigation was conducted into whether Dr. Kondejewski engaged in professional misconduct. In the face of these allegations, Dr. Kondejewski resigned from the College and has agreed never to apply or reapply for registration as a physician in Ontario. 

Download Full Document (PDF)
Source: Member
Effective Date: 12 Dec 2016
Summary:
Summary of the Undertaking given by Dr. Richard Joseph Kondejewski to the College of Physicians and Surgeons of Ontario, effective December 12, 2016:

Dr. Kondejewski, subject to the exceptions below, must not issue new prescriptions or renew existing prescriptions for any of the following substances:

(i) Narcotic Drugs (from the Narcotic Control Regulations made under the Controlled Drugs and Substances Act, S.C., 1996, c. 19);
(ii) Narcotic Preparations (from the Narcotic Control Regulations made under the Controlled Drugs and Substances Act, S.C., 1996, c. 19);
(iii) Controlled Drugs (from Part G of the Food and Drug Regulations under the Food and Drugs Act, S.C., 1985, c. F-27);
(iv) Benzodiazepines and Other Targeted Substances (from the Benzodiazepines and Other Targeted Substances Regulations made under the Controlled Drugs and Substances Act., S.C., 1996, c. 19);
(v) All other Monitored Drugs (as defined under the Narcotics Safety and Awareness Act, 2010, S.O. 2010, c. 22);
and as amended from time to time.

Exceptions:

(vi) Clonazepan for patients with seizure disorders;

(vii) Lorazepam for patients with claustrophobia who are scheduled to undergo an MRI/CT or where patients have a phobia of plane flights;

(viii) Lorazepam, as a sleeping aide, for patients who have been taking the medication for an extended period in which the medication was initiated by another physician;

(ix) ADHD patients requiring refills; and

(x) Testosterone for men receiving hormone replacement

Dr. Kondejewski must post a clearly visible sign in the waiting rooms of all his Practice Locations, setting out this information.

Current Tribunal Proceedings

No information available

Past Tribunal Proceedings

No information available

Other Notifications (2)

Source: Member
Effective Date: 08 Aug 2018
Summary:
Summary of the Undertaking given by Dr. Richard Joseph Kondejewski to the College of Physicians and Surgeons of Ontario, effective August 8, 2018:

A College investigation was conducted into whether Dr. Kondejewski engaged in professional misconduct. In the face of these allegations, Dr. Kondejewski resigned from the College and has agreed never to apply or reapply for registration as a physician in Ontario. 

Download Full Document (PDF)
Source: Member
Effective Date: 12 Dec 2016
Summary:
Summary of the Undertaking given by Dr. Richard Joseph Kondejewski to the College of Physicians and Surgeons of Ontario, effective December 12, 2016:

Dr. Kondejewski, subject to the exceptions below, must not issue new prescriptions or renew existing prescriptions for any of the following substances:

(i) Narcotic Drugs (from the Narcotic Control Regulations made under the Controlled Drugs and Substances Act, S.C., 1996, c. 19);
(ii) Narcotic Preparations (from the Narcotic Control Regulations made under the Controlled Drugs and Substances Act, S.C., 1996, c. 19);
(iii) Controlled Drugs (from Part G of the Food and Drug Regulations under the Food and Drugs Act, S.C., 1985, c. F-27);
(iv) Benzodiazepines and Other Targeted Substances (from the Benzodiazepines and Other Targeted Substances Regulations made under the Controlled Drugs and Substances Act., S.C., 1996, c. 19);
(v) All other Monitored Drugs (as defined under the Narcotics Safety and Awareness Act, 2010, S.O. 2010, c. 22);
and as amended from time to time.

Exceptions:

(vi) Clonazepan for patients with seizure disorders;

(vii) Lorazepam for patients with claustrophobia who are scheduled to undergo an MRI/CT or where patients have a phobia of plane flights;

(viii) Lorazepam, as a sleeping aide, for patients who have been taking the medication for an extended period in which the medication was initiated by another physician;

(ix) ADHD patients requiring refills; and

(x) Testosterone for men receiving hormone replacement

Dr. Kondejewski must post a clearly visible sign in the waiting rooms of all his Practice Locations, setting out this information.

Training

Medical School: University of Ottawa, 1971

Registration History

DETAILS DATE
Expired: Resigned from membership. Effective: 08 Aug 2018
Transfer of class of registration to: Restricted Certificate Effective: 12 Dec 2016
Arrow_iconTerms and conditions imposed on certificate by: Member Effective: 12 Dec 2016
First certificate of registration issued: Independent Practice Certificate Effective: 22 Jun 1972
DETAILS: Expired: Resigned from membership.
Date: Effective: 08 Aug 2018
DETAILS: Transfer of class of registration to: Restricted Certificate
Date: Effective: 12 Dec 2016
DETAILS: Terms and conditions imposed on certificate by: Member
Date: Effective: 12 Dec 2016
DETAILS: First certificate of registration issued: Independent Practice Certificate
Date: Effective: 22 Jun 1972